Pharmacology Flashcards
(120 cards)
Risk factors for PONV
Patient:
- Female
- non smoker
- h/o motion sickness
Anaesthesia:
- inhaled anaesthetic
- N2O
- intra and postop opioids
Surgery:
- duration > 30 min increases risk to 60%
- types (celioscopy, ENT, Neuro, breast, strabismus, laparotomy/laproscopic, plastic surgery
Risk scores for predicting PONV
Modified Apfel score
( 1 point for - female, non-smoker, Hx of PONV/motion sickness, post op opiates)
0 = 10%, 1=40%, 3=60%, 4=80%
POVOC score (paeds) 1 point for - duration >30 mins, age >3, strabismus, Hx PONV
Classes of antiemetics
Phenothiazines (Prochlorperazine) Butyrophenones (Droperidol) Benzamides (Metoclopramide) Anticholinergic (hyoscine) Antihistamine (cyclizine) 5-HT3 receptor antagonists (ondansetron) Miscellaneous (Dex, aprepitant)
Phenothiazines (example, MoA, SEs)
- Neuroleptics
- eg chlopromazide, prochlorperazine
- MoA antagonise dopamine D2, muscarinic and histamine H1 receptors in CTz
- SE extrapyrimidal (acute dystonias), neuroleptic malignant syndrome (rare)
Butyrophenones (example, MoA, SEs)
Butyrophenones (example, MoA, SEs)
Derivates are neuroleptics and antiemetics
- eg Droperidol
- MoA: dopamine D2 receptor antagonist at CTZ
- SE: extrapyrimidal and sedation
Domperidone - peripheral D2 receptor antagonist - doesn’t cross BBB therefore safe in parkinsons disease - SEs hyperprolactinaemia
Benzamides (example, MoA, SEs)
antiemetic and prokinetic
eg metoclopramide
Dopamine D2 receptor antagonist at CTZ and peripheral D2 receptor antagonist in stomach
Poor efficacy - equivocal with placebo (NNT ~ 10 and NN to do harm ~ 10)
SEs Extrapyrimidal, more common in young females, NMS (rare)
Anticholinergic antiemetics (example, MOA, SEs)
Eg Hyoscine
Centrally acting muscarinic
Transdermal patch
SE: anticholinergic .. dry mouth, tachy, blurred vision
Antihistamine antiemetics (example, MoA, SEs)
Cyclizine
H1 receptor antagonist in CTZ and some anticholinergic properties
SE mild anticholinergic SEs
5-HT3 receptor antagonists
Ondansetron
central and peripheral 5-HT3 antagonism
SE: headache, flushing, constipation, bradycardia (prolongs QT)
Miscellaneous antiemetics
Dexamethasone - unknown MoA, SEs sleep disturbance, raised BM
Aprepitant - Neurokinin 1 receptor antagonist (found in the GI tract), SEs - expensive (used in chemo)
Propofol (physical, Pk, Pd)
Propofol is 2,6-disioprophylphenol. It is commonly used throughout anaesthesia and critical care for induction and maintenance of anaesthesia and procedural sedation.
Physical:
It is a white lipid emulsion of soy bean oil and egg phosphatide. It is stable at room temperature and stored in glass vials of 200mg and 500mg.
For induction of anaesthesia dose of 2-3mg/kg for adults and 3-7mg/kg for children
Pk:
It is administered intravenously either as a bolus or continuous infusion.
It is highly lipid soluble and has a large volume of distribution
It is extensively protein bound
It is metabolised in the liver into glucuronide - an inactive metabolite and excreted renally - limited dose adjustment is required in liver/renal failure
It has a context sensitive half life between 30 min and 4 hours (?)
Pd:
CVS: Reduction in cardiac output via decreased HR and reduction in contractility. Decreased SVR causes further decrease in BP
RESP: bronchodilation. Decrease TV but increase in RR (?) - overall increase in PaCO2
CNS - anaesthesia, analgesic, myoclonic movements, decreased IOP/ICP/CMRO/CBF
GIT - antiemetic properties
Paediatrics - PIS - avoided for prolonged infusion in children due to accumulation of triglycerides …
Ketamine (physical, Pk, Pd)
Ketamine is a phencyclidine derivative. It is an NMDA antagonist used for sedation, induction of anaesthesia and analgesia. Also has weak agonist at MOP/KOP/DOP receptors plus inhibits re-uptake of serotonin, dopamine and noradrenaline
Physical:
It is a clear colourless liquid at room temperature, stored in glass vials of 10/50/100mg/ml
It is a racemic mixture s-ketamine is the more potent isomer.
Chemical:
Avaliable as racemic and single enantiomer preparations
Weak acid. water soluble solutions - pH 3.5-5.5
Pk
It can be administered IV/IM/PO/PR/intrathecal
Induction dose 1-2mg/kg IV and 5-10mg/kg IM
distribution - bioavaliability 20%, protein binding 20-50%, Vd 3l/kg, T1/2 2.5 hours
Metabolism - liver to norketamine an 30% as potent
Norketamine conjugated to inactive compound
excreted in the urine
Pd
CVS - sympatheticomemetic, increased HR/CO/BP/Cardiac O2 consumption
RESP - bronchodilation, increased RR, no laryngeal suppression
CNS - analgesia, dissociative anaesthesia, hallucinations/amnesia/emergence phenomenon, increased CBF/ICP/CMRO
GIT - nausea/vomiting, salivation
thiopentone (physical, Pk, Pd)
Thiopentone is a thiobarbituate used for induction of anaesthesia and a classical RSI
Physical:
Stored as an anhydrous yellow powder in nitrogen enviroment in glass vial with rubber lid. Reconstituted in water to create a solution with pH 10.8
Chemical:
Weak acid - pKa 7.6 - 60% ionised at 7.4
tauterisomerism - proportions of two forms depends on ambient pH
Pk
Administered IV at dose 3-7mg/kg for induction
Distribution - 80% protein bound, Vd 2l/kg
high lipid solubility with rapid emergence due to distribution
metabolism - liver via P450 - largely inactive except phenobarbitone. (P450 inducer). Exhibits zero-order kinetics with infusions
Pd
CVS - slight increase HR otherwise decrease in CO/SV/SVR
RESP - depression/bronchospasm/laryngospasm
CNS - hypnotic/ decreased CMRO/CBF/CSF
Other: severe anaphylaxis/precipitates porphyria
INTRA-ARTERIAL injection -> severe pain and vasospasm due to crystals forming and occluding peripheral arterioles
Etomidate (physical, Pk, Pd)
Etomidate is rarely used today for induction of anaesthesia. It is an imidazole hypnotic. It increases the duration of opening of GABA channels
Physical:
clear colourless solution avaliable in 2mg/ml in 10ml vial
Pk IV administration 0.3mg/kg 75% protein bound rapid distribution Vd 3 l/kg Metabolised by hepatic esterases and plasma esterases and excreted in urine (90%) and bile (10%)
Pd
CVS - most stable. slight decrease SVR. Myocardial O2 requirement stable. CO and BP stable
RESP - depression
CNS - hypnosis, tremor, involuntary movements, EPILEPTIFORM ACTIVITY 25%, decreased ICP/CPP/CMRO/IOP
GI -nausea and vomiting
Other:
- pain on injection
- contraindicated in porphyria
- hypersensitivity and histamine release
STEROID AXIS INHIBITION
- inhibits 11 beta and 17 alpha hydroxylase for 24 hours post dose
Management of intra-arterial injection of thiopentone
Aims: “dilute, dilate, analgesia, prevent thrombosis”
Stop injecting
flush with normal saline
IV PAPAVERINE (40-80mg)
IV lidocaine
IV heparin
Consider sympathetic blockage of upper limb
Continue anticoagulation for 10-14 days
Consult vascular surgery
How is nitrous oxide produced?
Ammonium nitrate is heated to 250 degrees
It decomposes into water and nitrous oxide
How is nitrous oxide stored?
French blue cylinders as a liquid below its critical temperature (36.5 degrees)
Pharmacodynamic effects of nitrous oxide
CVS
- reduces contractility but increases sympathetic outflow so BP unchanged
- increased pulmonary vascular resistance
RESP
- Decreased TV but increased RR - MV maintained
- blunt ventilatory response to hypoxia and hypercapnea
CNS
- Increases CBF, CMRO, ICP (effects more pronounced in patients who have lost autoregulatory ability - ie those with head injuries)
What are the physiochemical properties of nitrous oxide
Boiling point -88 degrees
Critical temperature 36.5 degrees
Blood/gas partition co-efficient 0.47
Oil/gas partition co-efficient 1.4
MAC 105% (only under hyperbaric conditions can it induce anaesthesia)
What are the adverse effects of nitrous oxide?
Nausea and vomiting
Expansion of N2O into cavities - it is more soluble than nitrogen so it diffuses into air filled cavities more quickly that nitrogen already in the cavity can diffuse into blood. Therefore CI for patient with pneumothorax or middle ear
It oxidises the cobalt ion in vitamin B12 and impairs its ability to act as a co-factor for methionine synthase - leads to bone marrow suppression, megaloblastic anaemia and subacute degeneration of spinal cord
Teratogenicity in rats
Green house gas
Define a partition co-efficient
A partition co-efficient is the ratio of the amount of substance in one phase to the amount in another at a stated temperature when the two phases are in equilibrium and of equal volumes and pressures
What is the blood:gas partition co-efficient?
The B:G coefficient is a measure of the solubility of a substance in blood and influences onset/offset times.
Onset time depends upon the PARTIAL PRESSURE in blood and not the total amount.
For agents that rapidly dissolve into the blood the alveolar pressure and partial pressure remain low. More molecules are required to saturate the blood and it takes a long time for equilibrium (FA/FI = 1)
Morphine (Physical, chemical, Pk, Pd)
Morphine is a naturally occurring phenanthrene derivative
It is used extensively for analgesia, sedation on ITU, palliative care and in heart failure
It acts directly on MOP & KOP G-protein receptors causing:
- closure of voltage gated Ca channels
- stimulation of K efflux
- decreased cAMP production
- All of which decrease neuronal excitability and reduced the likelihood of neurotransmitter release
It can be administered in many ways - IV/IM/SC/PO/intrathecal/epidural
Pk:
It is a weak acid with pKa of 8.0
It is well absorbed in the alkaline small bowel but undergoes extensive 1st pass metabolism so has a BIOAVALIABILITY of 15-20%
It is lipid soluble with a Vd 3-4L/kg and protein binding 20-40%
Peak effect 10-30 mins and duration 3-4 hours
Pd
CVS - no direct effect but can decrease SVR via histamine release and cause bradycardia by decreasing SNS
RR - dose dependent respiratory depressant (RR>TV), antitussive and decrease sensitivity to pCO2.
- bronchospasm if histamine release occurs
CNS - analgesia, sedation, euphoria, hallucinations, meiosis, (muscle rigidity and seizures at high doses)
GIT - nausea/vomiting, delayed gastric emptying, decreased gastric acid and bile secretion
GU - increased uterine tone
DERM - purititis/rash
ENDO - decreased ACTH and gonadotropic hormones. Increased ADH
What is dependence and addiction?
Dependence describes the need to repeatedly administer the drug to avoid withdrawal symptoms
Addiction describes the behaviour of a person resulting from their dependence - crave/need, have no control over their drugs use, use it compulsively and continue to use despite harm it causes